{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:33:34Z","timestamp":1790649214661,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T00:00:00Z","timestamp":1514246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background<\/jats:bold>: Lilly\/Avid's AV\u20101451 is one of the most advanced tau PET tracers in the clinic. Although results obtained in Alzheimer's disease patients are compelling, discrimination of tracer uptake in healthy individuals and patients with supranuclear palsy (PSP) is less clear as there is substantial overlap of signal in multiple brain regions. Moreover, accurate quantification of [<jats:sup>18<\/jats:sup>F]AV\u20101451 uptake in Alzheimer's disease may not be possible.<\/jats:p><jats:p><jats:bold>Objectives<\/jats:bold>: The aim of the present study was to characterize the in vitro binding of AV\u20101451 to understand and identify potential off\u2010target binding that could explain the poor discrimination observed in PSP patients.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold>: [<jats:sup>3<\/jats:sup>H]AV\u20101451 and AV\u20101451 were characterized in in vitro binding assays using recombinant and native proteins\/tissues from postmortem samples of controls and Alzheimer's disease and PSP patients.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>: [<jats:sup>3<\/jats:sup>H]AV\u20101451 binds to multiple sites with nanomolar affinities in brain homogenates and to tau fibrils isolated from Alzheimer's disease or PSP patients. [<jats:sup>3<\/jats:sup>H]AV\u20101451 also binds with similarly high affinities in brain homogenates devoid of tau pathology. This unexpected binding was demonstrated to be because of nanomolar affinities of [<jats:sup>3<\/jats:sup>H]AV\u20101451 for monoamine oxidase A and B enzymes.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> High affinity of AV\u20101451 for monoamine oxidase proteins may limit its utility as a tau PET tracer in PSP and Alzheimer's disease because of high levels of monoamine oxidase expression in brain regions also affected by tau deposition, especially if monoamine oxidase levels change over time or with a treatment intervention. \u00a9 2017 International Parkinson and Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.27271","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T05:49:07Z","timestamp":1514267347000},"page":"273-281","source":"Crossref","is-referenced-by-count":146,"title":["The tau positron\u2010emission tomography tracer AV\u20101451 binds with similar affinities to tau fibrils and monoamine oxidases"],"prefix":"10.1002","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-7061","authenticated-orcid":false,"given":"C\u00e9line","family":"Vermeiren","sequence":"first","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Motte","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Viot","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mairet\u2010Coello","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Philippe","family":"Courade","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Citron","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Mercier","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Hannestad","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc. South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Gillard","sequence":"additional","affiliation":[{"name":"UCB BioPharma sprl, Chemin du Foriest Braine l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150302170552"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2012.11.008"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-122059"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0315-6"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24517"},{"key":"e_1_2_8_7_1","unstructured":"McMillanC SchonhautD RussellD et al.Tau [18F]AV\u20101451 PET uptake in patients with suspected 4\u2010repeat tauopathy. Paper presented at: 10th International Conference on Frontotemporal Dementias; August 31\u2010September 2 2016; Munich Germany."},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0162-3"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.07.381"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171678"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00198a017"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(94)90140-6"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.08.032"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00688336"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90057-3"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199605000-00006"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410150302"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26844"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24844"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2013.19"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0253-y"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm104"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X16683695"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww340"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26834"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww098"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26813"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-005-0016-1"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.12-05-01977.1992"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00307-5"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.11.020"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90311-5"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.22.1.197"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.27271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.27271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mds.27271","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.27271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:45:50Z","timestamp":1760957150000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.27271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,26]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1002\/mds.27271"],"URL":"https:\/\/doi.org\/10.1002\/mds.27271","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,26]]}}}